RAFFA WEALTH MANAGEMENT, LLC’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.9K | Buy |
20
+6
| +43% | +$1.24K | ﹤0.01% | 649 |
|
|
2026
Q1 | $3.14K | Hold |
14
| – | – | ﹤0.01% | 640 |
|
|
2025
Q4 | $3.37K | Hold |
14
| – | – | ﹤0.01% | 600 |
|
|
2025
Q3 | $3.83K | Hold |
14
| – | – | ﹤0.01% | 541 |
|
|
2025
Q2 | $3.61K | Hold |
14
| – | – | ﹤0.01% | 561 |
|
|
2025
Q1 | $3.13K | Hold |
14
| – | – | ﹤0.01% | 533 |
|
|
2024
Q4 | $3.2K | Hold |
14
| – | – | ﹤0.01% | 542 |
|
|
2024
Q3 | $3.42K | Hold |
14
| – | – | ﹤0.01% | 507 |
|
|
2024
Q2 | $2.68K | Hold |
14
| – | – | ﹤0.01% | 648 |
|
|
2024
Q1 | $2.77K | Hold |
14
| – | – | ﹤0.01% | 628 |
|
|
2023
Q4 | $2.41K | Hold |
14
| – | – | ﹤0.01% | 562 |
|
|
2023
Q3 | $2.07K | Sell |
14
-9
| -39% | -$1.63K | ﹤0.01% | 575 |
|
|
2023
Q2 | $5.03K | Hold |
23
| – | – | ﹤0.01% | 394 |
|
|
2023
Q1 | $5.04K | Hold |
23
| – | – | ﹤0.01% | 405 |
|
|
2022
Q4 | $4.79K | Hold |
23
| – | – | ﹤0.01% | 395 |
|
|
2022
Q3 | $5.02K | Hold |
23
| – | – | ﹤0.01% | 387 |
|
|
2022
Q2 | $4.82K | Sell |
23
-1
| -4% | -$213 | ﹤0.01% | 400 |
|
|
2022
Q1 | $5.82K | Buy |
24
+1
| +4% | +$242 | ﹤0.01% | 380 |
|
|
2021
Q4 | $5.99K | Hold |
23
| – | – | ﹤0.01% | 392 |
|
|
2021
Q3 | $6.06K | Hold |
23
| – | – | ﹤0.01% | 340 |
|
|
2021
Q2 | $5.67K | Hold |
23
| – | – | ﹤0.01% | 354 |
|
|
2021
Q1 | $4.46K | Buy |
23
+1
| +5% | +$201 | ﹤0.01% | 423 |
|
|
2020
Q4 | $4.68K | Hold |
22
| – | – | ﹤0.01% | 371 |
|
|
2020
Q3 | $3.77K | Buy |
22
+5
| +29% | +$923 | ﹤0.01% | 374 |
|
|
2020
Q2 | $3.26K | Hold |
17
| – | – | ﹤0.01% | 382 |
|
|
2020
Q1 | $2.5K | Buy |
17
+6
| +55% | +$956 | ﹤0.01% | 384 |
|
|
2019
Q4 | $1.71K | Hold |
11
| – | – | ﹤0.01% | 431 |
|
|
2019
Q3 | $1.49K | Buy |
+11
| New | +$1.44K | ﹤0.01% | 461 |
|
|
2019
Q2 | – | Sell |
-1,251
| Closed | -$130K | – | 1253 |
|
|
2019
Q1 | $130K | Sell |
1,251
-60
| -5% | -$6.19K | 0.05% | 73 |
|
|
2018
Q4 | $149K | Sell |
1,311
-1,600
| -55% | -$171K | 0.06% | 81 |
|
|
2018
Q3 | $336K | Buy |
2,911
+1,000
| +52% | +$110K | 0.12% | 61 |
|
|
2018
Q2 | $198K | Sell |
1,911
-1,500
| -44% | -$152K | 0.07% | 68 |
|
|
2018
Q1 | $336K | Buy |
3,411
+11
| +0.3% | +$1.04K | 0.12% | 58 |
|
|
2017
Q4 | $288K | Sell |
3,400
-350
| -9% | -$28.9K | 0.11% | 68 |
|
|
2017
Q3 | $289K | Hold |
3,750
| – | – | 0.12% | 69 |
|
|
2017
Q2 | $292K | Hold |
3,750
| – | – | 0.13% | 65 |
|
|
2017
Q1 | $270K | Hold |
3,750
| – | – | 0.13% | 47 |
|
|
2016
Q4 | $233K | Buy |
3,750
+230
| +7% | +$14.1K | 0.12% | 50 |
|
|
2016
Q3 | $228K | Sell |
3,520
-241
| -6% | -$16K | 0.12% | 51 |
|
|
2016
Q2 | $238K | Hold |
3,761
| – | – | 0.13% | 50 |
|
|
2016
Q1 | $217K | Buy |
3,761
+111
| +3% | +$6.28K | 0.12% | 51 |
|
|
2015
Q4 | $196K | Hold |
3,650
| – | – | 0.12% | 48 |
|
|
2015
Q3 | $186K | Buy |
3,650
+250
| +7% | +$13.5K | 0.11% | 51 |
|
|
2015
Q2 | $192K | Sell |
3,400
-825
| -20% | -$52.1K | 0.11% | 51 |
|
|
2015
Q1 | $303K | Sell |
4,225
-1,200
| -22% | -$77.9K | 0.18% | 34 |
|
|
2014
Q4 | $304K | Buy |
5,425
+75
| +1% | +$3.92K | 0.18% | 36 |
|
|
2014
Q3 | $264K | Buy |
5,350
+80
| +2% | +$4.08K | 0.2% | 38 |
|
|
2014
Q2 | $267K | Buy |
5,270
+53
| +1% | +$2.63K | 0.2% | 39 |
|
|
2014
Q1 | $233K | Sell |
5,217
-208
| -4% | -$9.34K | 0.19% | 41 |
|
|
2013
Q4 | $304K | Buy |
+5,425
| New | +$275K | 0.18% | 36 |
|
Other funds holding RMD
VF
AT
CISOA
DJSG
MIF
CIM
RAFFA WEALTH MANAGEMENT, LLC's RMD Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its ResMed (RMD) stake by 43% in Q2 2026, buying an estimated $1.24K and bringing the position to 20 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #649.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in RMD in Q4 2013 and has held it in 50 quarters since. The position peaked at $336K in Q1 2018. 222 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 20 shares of ResMed worth $3.9K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 6 ResMed shares in Q2 2026, an estimated $1.24K.
- ResMed made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #649 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in ResMed in Q4 2013 and has held it in 50 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's ResMed position peaked at $336K in Q1 2018.
- 222 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.